Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2019 First Quarter, which ended June 2, 2018, on Wednesday, June 27, 2018.
During the week we scaled into two existing positions and added back shares of a former holding.
During the week we added to our cannabis play Kush Bottles and took a nice win on J.Jill.
We will add to Rite Aid as we expect benefits of the pending merger with Albertsons to be increasingly recognized.
Rite Aid Corporation (NYSE: RAD) announced today that it plans to install 100 medication disposal units in select pharmacies over the next year, the latest measure being taken by Rite Aid as part of its comprehensive strategy to address drug abuse and...
Last week we trimmed USA Technologies and added LendingClub to the Bullpen.
As part of its commitment to improving the lives of children in communities served by Rite Aid, The Rite Aid Foundation announced today the launch of its KidCents Regional Grant Program.
Rite Aid Corporation (NYSE: RAD) today announced the results of its previously announced offer to purchase (the "Asset Sale Offer") up to $700,000,000 of certain of its outstanding indebtedness, consisting of its outstanding 6.
We trimmed one position for a hefty gain last week, as the portfolio delivered very favorable performance on both an absolute and relative basis.
Rite Aid Corporation (NYSE: RAD) announced today that DisposeRx, a first-of-its-kind opioid disposal solution, is now available at all of Rite Aid's more than 2,500 pharmacies across the United States.
Wall Street is on pins and needles waiting for Amazon to announce its plans to get into the healthcare space. If Amazon opts to get into the pharmacy space, the financial impact to Walgreens and Rite Aid could be devastating.
The Rite Aid Foundation announced today that Cathryn Tames, Executive Director of the Children's Developmental Center in Richland, Washington, has been awarded its KIDCHAMP SM Award for her tireless work over the past 30 years to support children with...
In response to the nation's opioid epidemic, pharmacy benefit manager, EnvisionRx, a division of EnvisionRxOptions, announced enhancements to its comprehensive opioid and pain management program, EnvisionCare Pain Management.
Here's what you need to know now for Tuesday, May 15.
We added 2 new positions during a week of solid performance for the portfolio.
Albertsons Companies, Inc. one of the nation's largest grocery retailers, and Rite Aid Corporation (NYSE:RAD), one of the nation's leading drugstore chains, announced today that they will host a joint analyst event on May 15, 2018.
We added to three positions during a mixed week for the market.
MedTrakRx, a pharmacy benefit manager (PBM) and a division of EnvisionRxOptions (a wholly owned subsidiary of Rite Aid), was recently selected by the Kansas City Business Journal as a 2018 Champion of Business award winner.
During a down week for the market, we exited one name and added to another.
We will add to AXT Inc., LSI Industries and Rite Aid this morning.
If anyone can sell it to antitrust regulators, T-Mobile CEO John Legere can.
We initiated one position and closed out another last week.
Rite Aid Corporation (NYSE: RAD) today announced that it has commenced an offer to purchase for cash (the "Asset Sale Offer") up to $700,000,000 of certain of its outstanding indebtedness, consisting of its 6.
Rite Aid Corporation (NYSE: RAD) announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is available at each of the more than 2,500 Rite Aid pharmacies in the United States and can be dispensed without a...
We added to two positions during a week when nearly all of our holdings moved higher.
Stocks rise Thursday after Donald Trump says a missile strike in Syria isn't imminent.
The world remains dangerous, and dangerous toys are not just simply in demand -- demand is increasing rapidly.
U.S. stock futures rise; Delta Air Lines and BlackRock report earnings; Facebook's value soars during Mark Zuckerberg's congressional testimony; Tesla reportedly targets November 2019 for start of Model Y production.
